Il Dosaggio R.I.A. Della Beta 2 Microglobulina Come Marker Del Cancro Della Prostata

Berggärd Bearn : Isolation and properties of a low molecular weight B₂ globulin occurring in human biological fluids. J. Biol. Chem., 243; 4095 (1968).

Revillard Vincent : Clinical significance of B₂ MG determination. Acta Clin. Belg., 35; Suppl., 10 (1980).

Vree Guelen : The relathionship between the renal clearance of creatinine and the apparent renal clearance of B₂ MG in patients with normal and impaired kidney function. Gin. Chim. Acta, 114; 93–99 (1981).

Schentaly J. : Early detection of aminoglycoside nephrotoxiticy with urinary B₂ MG. J. Med. PJD Publ. Ltd. 1978.

Daver : B₂ MG and CEA in cancer pathology. Symposium on B₂ MG in proliferative disorders. Peterson , and Lauwerys ed. F, Brussels 1977.

Pluygers Beauduin : The determination of B₂ microglobulin in cancer patterns. A comparision with CEA levels. Symposium on B₂ MG in proliferative disorders. Peterson and Lauwerys ed. Brussels 1977.

Shuster Gold , Poulik : B₂ MG levels in cancerous and other disease states. Gin. Chim. Acta, 67; 307–313 (1976).

Hall Gren , Lundqvist : Serum B₂ MG in patients with bronchial carcinomic controls. Cancer, 45; 780–785 (1980).

Mavlight : Diagnosis of leukemia. N. Engl. J. Med., 303; 718 (1980).

Rowen A. : Serum beta₂ microglobulin levels in urological cancer. J. Urol., 121; 624–625 (1979).

Wibell L. B. : Studies on B₂ microglobulin in patients and normal subjects. Acta Gin. Berg., 31; suppl. 14 (1976).

Dimopoulos C. : Dosage de la B₂ microblobuline sérique dans le cancer de la vessie. J. d'Urol., 88; 11–13 (1982).